SLGL
Sol-Gel Technologies Ltd.
NASDAQ · ILHealthcareBiotechnology
$80.10-3.73%
Price as of Jul 20, 2026
SLGL capital
Sol-Gel Technologies Ltd. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.02x
- Net debt / equity
- -0.18x
- Debt / assets
- 0.01x
- Debt / EBITDA
- -0.44x
- Net debt / EBITDA
- 4.69x
Liquidity & coverage
- Current ratio
- 8.84x
- Quick ratio
- 8.84x
- Cash ratio
- 8.37x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $49.5M
Cash & dividend
- FCF / debt
- 0.32x
- Cash flow / debt
- 0.37x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.